REQUEST A DEMO
Total
USD $0.00
Search more companies

Proclin Pharma S A (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Proclin Pharma S A Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Distribucion, representacion, comercializacion, fabricacion, importacion y exportacion de toda clase de medicamentos de uso humano y veterinario de uso en general.

Headquarters
Cra 68 D 98 A 73
Bogota D.C.; Bogota D.C; Postal Code: 0825

Contact Details: Purchase the Proclin Pharma S A report to view the information.

Basic Information
Total Employees:
Purchase the Proclin Pharma S A report to view the information.
Outstanding Shares:
Purchase the Proclin Pharma S A report to view the information.
Registered Capital:
Purchase the Proclin Pharma S A report to view the information.
Incorporation Date:
March 29, 1990
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Proclin Pharma S A report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
34.15%
Total operating revenue
33.62%
Operating profit (EBIT)
137.55%
EBITDA
156.39%
Net Profit (Loss) for the Period
152.19%
Total assets
17.1%
Total equity
37.87%
Operating Profit Margin (ROS)
5.01%
Net Profit Margin
3.35%
Return on Equity (ROE)
3.73%
Debt to Equity Ratio
-16.16%
Quick Ratio
0.1%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?